Integra LifeSciences Holdings Corporation
IART · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.64B | $1.61B | +1.5% |
| Operating income | −$493M | $28.4M | |
| Net income | −$516M | −$6.94M | −7,342% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 23, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $411M | $402M | +2.3% |
| Operating income | $18.9M | $11.8M | +60.2% |
| Net income | $14.9M | −$5.40M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Integra's revenue in FY2025?
- $1.64B in FY2025 (Fiscal year ended Dec 31, 2025), +1.5% vs $1.61B a year earlier, per its 10-K filed Feb 2026.
- Was Integra profitable in FY2025?
- No: net income was −$516M and operating income −$493M in FY2025.
- What was Integra's revenue in Q3 2026?
- $411M (+2.3% vs a year earlier), per its Form 10-Q filed Oct 23, 2026.